• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

深度行为表征学习揭示恶性室性心律失常的风险特征。

Deep behavioural representation learning reveals risk profiles for malignant ventricular arrhythmias.

作者信息

Kolk Maarten Z H, Frodi Diana My, Langford Joss, Andersen Tariq O, Jacobsen Peter Karl, Risum Niels, Tan Hanno L, Svendsen Jesper Hastrup, Knops Reinoud E, Diederichsen Søren Zöga, Tjong Fleur V Y

机构信息

Department of Clinical and Experimental Cardiology, Amsterdam UMC Location University of Amsterdam, Heart Center, Meibergdreef 9, Amsterdam, the Netherlands.

Amsterdam Cardiovascular Sciences, Heart Failure & Arrhythmias, Amsterdam UMC location AMC Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands.

出版信息

NPJ Digit Med. 2024 Sep 16;7(1):250. doi: 10.1038/s41746-024-01247-w.

DOI:10.1038/s41746-024-01247-w
PMID:39284923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11405885/
Abstract

We aimed to identify and characterise behavioural profiles in patients at high risk of SCD, by using deep representation learning of day-to-day behavioural recordings. We present a pipeline that employed unsupervised clustering on low-dimensional representations of behavioural time-series data learned by a convolutional residual variational neural network (ResNet-VAE). Data from the prospective, observational SafeHeart study conducted at two large tertiary university centers in the Netherlands and Denmark were used. Patients received an implantable cardioverter-defibrillator (ICD) between May 2021 and September 2022 and wore wearable devices using accelerometer technology during 180 consecutive days. A total of 272 patients (mean age of 63.1 ± 10.2 years, 81% male) were eligible with a total sampling of 37,478 days of behavioural data (138 ± 47 days per patient). Deep representation learning identified five distinct behavioural profiles: Cluster A (n = 46) had very low physical activity levels and a disturbed sleep pattern. Cluster B (n = 70) had high activity levels, mainly at light-to-moderate intensity. Cluster C (n = 63) exhibited a high-intensity activity profile. Cluster D (n = 51) showed above-average sleep efficiency. Cluster E (n = 42) had frequent waking episodes and poor sleep. Annual risks of malignant ventricular arrhythmias ranged from 30.4% in Cluster A to 9.8% and 9.5% for Clusters D-E, respectively. Compared to low-risk profiles (D-E), Cluster A demonstrated a three-to-four fold increased risk of malignant ventricular arrhythmias adjusted for clinical covariates (adjusted HR 3.63, 95% CI 1.54-8.53, p < 0.001). These behavioural profiles may guide more personalised approaches to ventricular arrhythmia and SCD prevention.

摘要

我们旨在通过对日常行为记录进行深度表征学习,识别并描述猝死高危患者的行为特征。我们提出了一种流程,该流程对卷积残差变分神经网络(ResNet-VAE)学习到的行为时间序列数据的低维表征进行无监督聚类。使用了来自荷兰和丹麦两个大型三级大学中心进行的前瞻性观察性SafeHeart研究的数据。患者在2021年5月至2022年9月期间接受了植入式心律转复除颤器(ICD),并在连续180天内佩戴使用加速度计技术的可穿戴设备。共有272名患者(平均年龄63.1±10.2岁,81%为男性)符合条件,共采集了37478天的行为数据(每位患者138±47天)。深度表征学习识别出五种不同的行为特征:A组(n = 46)身体活动水平极低且睡眠模式紊乱。B组(n = 70)活动水平高,主要为轻度至中度强度。C组(n = 63)表现出高强度活动特征。D组(n = 51)睡眠效率高于平均水平。E组(n = 42)有频繁的觉醒发作且睡眠质量差。恶性室性心律失常的年度风险在A组为30.4%,在D组和E组分别为9.8%和9.5%。与低风险特征组(D - E)相比,A组经临床协变量调整后,恶性室性心律失常风险增加了三到四倍(调整后HR 3.63,95% CI 1.54 - 8.53,p < 0.001)。这些行为特征可能会为室性心律失常和猝死的预防指导更个性化的方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/51407724c1bc/41746_2024_1247_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/b8ef1cf6df84/41746_2024_1247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/b447dd444c70/41746_2024_1247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/448c1a1b3db8/41746_2024_1247_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/51407724c1bc/41746_2024_1247_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/b8ef1cf6df84/41746_2024_1247_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/b447dd444c70/41746_2024_1247_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/448c1a1b3db8/41746_2024_1247_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8029/11405885/51407724c1bc/41746_2024_1247_Fig4_HTML.jpg

相似文献

1
Deep behavioural representation learning reveals risk profiles for malignant ventricular arrhythmias.深度行为表征学习揭示恶性室性心律失常的风险特征。
NPJ Digit Med. 2024 Sep 16;7(1):250. doi: 10.1038/s41746-024-01247-w.
2
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用:基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Dynamic prediction of malignant ventricular arrhythmias using neural networks in patients with an implantable cardioverter-defibrillator.使用神经网络对植入式心脏复律除颤器患者恶性室性心律失常进行动态预测。
EBioMedicine. 2024 Jan;99:104937. doi: 10.1016/j.ebiom.2023.104937. Epub 2023 Dec 19.
5
Mortality Risk Increases With Clustered Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators.植入式心脏复律除颤器患者中,室性心律失常成簇发作会增加死亡风险。
JACC Clin Electrophysiol. 2020 Mar;6(3):327-337. doi: 10.1016/j.jacep.2019.11.012. Epub 2020 Jan 29.
6
Rationale and design of the SafeHeart study: Development and testing of a mHealth tool for the prediction of arrhythmic events and implantable cardioverter-defibrillator therapy.SafeHeart研究的基本原理与设计:一种用于预测心律失常事件和植入式心律转复除颤器治疗的移动健康工具的开发与测试。
Cardiovasc Digit Health J. 2021 Oct 13;2(6 Suppl):S11-S20. doi: 10.1016/j.cvdhj.2021.10.002. eCollection 2021 Dec.
7
Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.用于治疗心律失常的植入式心脏复律除颤器和用于治疗心力衰竭的心脏再同步治疗:系统评价与经济学评估
Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560.
8
Fatal ventricular arrhythmias in myocarditis: A review of current indications for defibrillator devices.心肌炎中的致命性室性心律失常:对除颤器设备现有适应证的综述。
J Cardiol. 2024 Sep;84(3):151-154. doi: 10.1016/j.jjcc.2024.03.007. Epub 2024 Mar 27.
9
10
[Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].[扩张型心肌病患者植入式心脏复律除颤器在心脏性猝死一级预防中有无再同步治疗的心律失常、器械干预及死亡率分析]
Pol Merkur Lekarski. 2016 Apr;40(238):216-22.

本文引用的文献

1
Dynamic prediction of malignant ventricular arrhythmias using neural networks in patients with an implantable cardioverter-defibrillator.使用神经网络对植入式心脏复律除颤器患者恶性室性心律失常进行动态预测。
EBioMedicine. 2024 Jan;99:104937. doi: 10.1016/j.ebiom.2023.104937. Epub 2023 Dec 19.
2
Behavioural digital biomarkers enable real-time monitoring of patient-reported outcomes: a substudy of the multicentre, prospective observational SafeHeart study.行为数字化生物标志物可实现患者报告结局的实时监测:多中心前瞻性观察性 SafeHeart 研究的子研究。
Eur Heart J Qual Care Clin Outcomes. 2024 Sep 13;10(6):531-542. doi: 10.1093/ehjqcco/qcad069.
3
Association between accelerometer-derived physical activity and incident cardiac arrest.
基于加速度计的身体活动与心搏骤停事件的关联。
Europace. 2023 Dec 6;25(12). doi: 10.1093/europace/euad353.
4
Wearable-based accelerometer activity profile as digital biomarker of inflammation, biological age, and mortality using hierarchical clustering analysis in NHANES 2011-2014.基于可穿戴设备的加速度计活动特征作为炎症、生物年龄和死亡率的数字生物标志物,使用 NHANES 2011-2014 中的层次聚类分析。
Sci Rep. 2023 Jun 8;13(1):9326. doi: 10.1038/s41598-023-36062-y.
5
Predicting Malignant Ventricular Arrhythmias Using Real-Time Remote Monitoring.使用实时远程监测预测恶性室性心律失常。
J Am Coll Cardiol. 2023 Mar 14;81(10):949-961. doi: 10.1016/j.jacc.2022.12.024.
6
Association of accelerometer-derived circadian abnormalities and genetic risk with incidence of atrial fibrillation.加速度计衍生的昼夜节律异常和遗传风险与心房颤动发生率的关联。
NPJ Digit Med. 2023 Mar 4;6(1):31. doi: 10.1038/s41746-023-00781-3.
7
Wearable Devices in Cardiovascular Medicine.可穿戴设备在心血管医学中的应用
Circ Res. 2023 Mar 3;132(5):652-670. doi: 10.1161/CIRCRESAHA.122.322389. Epub 2023 Mar 2.
8
Machine learning of electrophysiological signals for the prediction of ventricular arrhythmias: systematic review and examination of heterogeneity between studies.机器学习在电生理信号预测中的应用:系统综述及研究间异质性的考察。
EBioMedicine. 2023 Mar;89:104462. doi: 10.1016/j.ebiom.2023.104462. Epub 2023 Feb 9.
9
Incidence of Sudden Cardiac Death in the European Union.欧盟的心脏性猝死发生率。
J Am Coll Cardiol. 2022 May 10;79(18):1818-1827. doi: 10.1016/j.jacc.2022.02.041.
10
Accelerometer-assessed physical behavior and the association with clinical outcomes in implantable cardioverter-defibrillator recipients: A systematic review.加速度计评估的身体行为及其与植入式心脏复律除颤器接受者临床结局的关联:一项系统综述。
Cardiovasc Digit Health J. 2021 Nov 24;3(1):46-55. doi: 10.1016/j.cvdhj.2021.11.006. eCollection 2022 Feb.